Abstract
Purpose: Pancreatic adenocarcinoma has a high prevalence all over the world. Most of the therapeutic approaches failed as a result of tumor invasion and rapid metastasis. Several natural plants have been shown to have promising therapeutic effects. Thus, the aim of this study was to investigate the cytotoxic activity of Eryngium billardieri against PANC-1 cancer cell lines.
Methods: Dimethylthiazole diphenyltetrazolium bromide assay (MTT assay) and flow cytometry were used to assess the cytotoxicity of E. billardieri extracts against PANC-1 cancer cell lines. Quantitative Polymerase Chain Reaction (qPCR) was conducted to investigate the expression levels of Bcl2- associated X protein (BAX) and cyclin D1.
Results: The results of the MTT assay showed that E. billardieri extracts had cytotoxic effects on PANC- 1 cancer cell lines. Moreover, the findings from the gene expression confirmed the over expression of Bax, and under expression of cyclin D1 following treatment with dichloromethane (DCM) and n-hexane (n- hex) extracts in cancer cells (P < 0.05). Interestingly, the flow cytometry results showed that DCM and n- hex extracts of E. billardieri induced apoptosis in PANC- 1 cancer cell lines.
Conclusion: The results of this study demonstrated that DCM and n- hex extracts of E. billardieri significantly induce apoptosis by increasing Bax and decreasing cyclin D1 mRNA expression. Therefore, E. billardieri may be regarded as a novel approach for treatment of pancreatic cancer as a result of its promising apoptotic and cytotoxic properties.
Keywords: Adenocarcinoma, Bax, Cyclin D1, Eryngium, Pancreas
Introduction
Pancreatic adenocarcinoma is one of the most lethal malignant neoplasms across the world, and is associated with the lowest 5-year survival rate.1 According to the GLOBOCAN 2012 estimates, pancreatic cancer accounts for more than 331000 deaths per year, making it the third leading cause of cancer death in both sexes together.2 The major barrier to positive clinical outcomes for this type of cancer is delayed diagnosis and resistance to existing malignancy therapeutics.3
Apoptosis, as a major mechanism which regulates pathways to control cell proliferation and death, is suggested for consideration as one of the targeted therapy strategies for tumor cells.4 In recent years, a number of investigations have been carried out that show novel strategies for more successful prevention and therapy of pancreatic cancer. Previous studies demonstrated that cyclin D1 and Bax genes are the most important regulators in controlling the proliferation and apoptosis of cells.5
Cyclin D1 protein plays a crucial role in regulating the progress of the cell during the G1 phase of the cell cycle. The cyclin D1 gene is intensified in pancreatic carcinomas.6 Proapoptotic Bax protein can induce apoptosis via the intrinsic signaling pathway (also known as mitochondrial apoptosis).7,8 Previous findings suggest that enhanced apoptosis-promoting Bax gene expression may have therapeutic application in pancreatic cancer cells.9,10
Pioneering clinical studies have reported that medicinal herbs and their derivative phytocompounds can be considered as useful complementary treatments for cancer.11,12E. billardieri (Figure 1) belongs to the Umbelliferae family which is used extensively as a medicinal plant worldwide for the treatment of various inflammatory disorders.13 In Iranian folk medicine, various parts of this plant are used for a wide range of ailments; such as various inflammatory disorders, rheumatism, sinusitis, wound healing, urinary infections, scorpion bites, goiter etc.13,14 Extracts obtained from the root and aerial parts of E. billardieri previously showed anti-inflammatory and anti-hyperglycemic effects.15,16
The dim prognosis of pancreatic adenocarcinoma is due to a lack of molecular pathways regarding disease development. PANC-1 cell lines (Pancreatic cancer cell lines) are currently used as in vitro models to assay pancreatic ductal adenocarcinoma carcinogenesis. The morphological and genetic characteristics of these cell lines are well- known already.17 In continuation of our scientific works on the evaluation of the anti-proliferative activity of the Iranian Medicinal plants,18-25 this study investigated the cytotoxic activity of n-hex, DCM and methanol (Met) extracts of the aerial parts of E. billardieri against PANC-1 cancer cell lines via Bax and cyclin D1 mRNA expression.
Materials and Methods
Materials
Methanol, L-glutamine, Penicillin-Streptomycin, MTT, Phosphate-buffered saline (PBS), Trypsin-Ethylenediaminetetraacetic acid (EDTA) solution, and RPMI 1640 were purchased from Sigma (Sigma, St. Louis, MO, USA). Fetal bovine serum (FBS) (HyClone, Logan, UT, USA), Dimethyl sulfoxide (DMSO), Diethyl pyrocarbonate (DEPC) water (Merck, Germany), AnnexinV-FITC/PI apoptosis kit (Invitrogen, USA), SYBR Green PCR master mix (Takara Bio Inc., Tokyo, Japan) were used in this study.
Plant materials were collected from Maragheh- Mountains (Eastern Azerbaijan Province, Iran). Voucher specimens were authenticated by Herbarium of Faculty of Pharmacy, Tabriz University of Medical Sciences. The fresh aerial parts of E. billardieri (100 g) were extracted with 1.1 L of n-hex, DCM and MeOH solvents by Soxhlet apparatus, respectively. Then, to reach the highest purity percentage, the extract was filtered by Whatman filter paper no.40 and was placed in the temperature of 36°C. To yield a dry and concentrated extract, rotary vacuum evaporator was used. Extracts were kept in sterile screw-capped containers and were stored at 6°C until use.
PANC-1 and human embryonic kidney normal cell line (KDR/293) were obtained from the Pasteur Institute, National cell bank, Tehran, Iran. The cells were grown in RPMI 1640 medium (Sigma, St. Louis, MO, USA) which were supplemented with 10% FBS, penicillin G (100 U/ml), and streptomycin (100 µg/ml). Cells were cultured in 25 cm2 culture T- flasks at 37°C in humidified air with 5% CO2.
MTT assay, gene expression and flow cytometry
In-vitro, cytotoxicity was assessed by 3-[4, 5-dimethylthiazol-2-yl]-3, 5-diphenyl tetrazolium bromide for treated and untreated PANC- 1 and KDR/293 cell lines. MTT assay is a high accuracy colorimetric method that is widely used to determine cell viability and cell cytotoxicity, particularly in the expansion of new drugs. The cells were seeded in 96-well plates at a density of 15,000 cells per well in their respective RPMI 1640 media. When the cells were approximately more than 80% confluent were left untreated or treated with DCM, MeOH and n-hex extracts of E. billardieri. The half maximal inhibitory concentration (IC50) was determined by MTT test in the range of 0 to 1600 µg/mL at 24 and 48 hours (Figure 2).
Analyses of Bax and cyclin D1 genes expression were all performed after 48 hours of E. billardieri treatment by reverse transcription-polymerase chain reaction. Total RNA was extracted from cultured cell lines using TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions. β- actin was considered as an internal control. The relative absorbance ratio at A260/280 and A260/230 on a spectrophotometer (NanoDrop One/Onec, Thermo Scientific) was used to confirm RNA quality and quantity. Total RNA was then converted to cDNA by reverse transcription using Prime Script RT Reagent kit (Takara, RR037Q, Japan) according to manufacturer's recommendations for cDNA synthesis. For qRT-PCR, three replicates of each sample were amplified in a 20 μL reaction mixture containing SYBR Green reaction mix (Takara, Japan) and 0.5 mM of primer and analyzed using real-time PCR (Mic –qPCR, Australia). The amount of the Bax and cyclin D1 mRNA were normalized against that of the β- actin mRNA and the relative mRNA abundance was analyzed using -2ΔΔCT method.26 The primer sequences were designed through the use of PrimerBank and summarized in supplementary appendix (Table 1). PANC- 1 and KDR/293 cells were seeded into six-well culture plates (1.0×106 cells/well) with RPMI 1640 media and incubated at growth condition for 48 h. After that, the cells were washed with pre-warmed culture media and were carefully replaced with a prepared fixative solution (pre-warmed RPMI containing 4% formaldehyde). Cells were treated with 50, 100 and 200 µg/mL of DCM, Met, and n-hex extracts of E. billardieri. After treatment time point (48 h), the untreated and treated cells were separated by Trypsin-EDTA, and supernatants were thrown away after centrifugation at 900 rpm for 10 min at 28°C. According to the AnnexinV-FITC/PI apoptosis kit (Invitrogen, USA) instructions, the cell pellets were washed once in PBS, then once in 1X Binding Buffer and were centrifuged and disposed supernatant in each phase. After this stage, the cells were resuspended in 100 µl of 1X binding buffer and were transferred into a new 5 ml tube. Then, 5 µl of FITC-conjugated Annexin V was added to 100 μL of the cell suspension and incubated for 15 min under a dark condition at room temperature. After incubation time, the cells were washed with 1X binding buffer and resuspended in 200 μL of 1X binding buffer again. At the final stage, 5 µl of propidium iodide (PI) staining solution was added to the cells and was analyzed by flow cytometry. Quadrant settings were fixed with untreated controls and copied to dot plots of the treated cells. Data analysis was done using FlowJo (Treestar, Inc., San Carlos, CA). The experiment was repeated triplicate.
Table 1. Sequence of Genes primers for qRT-PCR .
Gene | Primers | |
Bax | Forward | TTCTGACGGCAACTTCAACT |
Reverse | CAGCCCATGATGGTTCTGAT | |
Cyclin- D1 | Forward | CCACTCCTACGATACGCTACTA |
Reverse | CCAGCATCTCATAAACAGGTCA | |
β-actin | Forward | GGTGAAGGTGACAGCAGT |
Reverse | TGGGGTGGCTTTTAGGAT |
Statistical analysis
Graph Pad Instat 6 software (GraphPad Instant biostatistics, San Diego, CA, USA) was used to test significant differences between various treatment groups. All data are expressed as means ± SD. Analysis of the experimental data was done by using the one-way ANOVA analysis of variance; following Tukey’s post hoc using SPSS (SPSS Inc. Chicago, IL, USA version 16.0). P-values less than 0.05 were considered to be significant.
Results
E.billardieri extracts had cytotoxic effects on PANC- 1 cancer cell lines
To determine the cytotoxic effects of E. billardieri extracts on PANC-1 and KDR/293 cells MTT assay was performed. Data analysis of cells treated with plant extract at 0- 1600 µg/mL concentrations in 24 & 48 h is illustrated in Figure 2. Moreover, the half-maximal inhibitory concentrations (IC50) after treatment by various concentrations of DCM, Met and n-hex extracts of E. billardieri were determined and presented in Table 2. As seen in Figure 2, due to the treatment by Met, DCM and n-hex extracts of E. billardieri the survival rates of PANC- 1 cells were significantly decreased compared with untreated cell lines (p<0.05) in time and dose dependent manner. However, as shown in Figure 2, the extracts had growth inhibitory effect on the KDR/293 normal cell only in high concentrations which IC50 could not be defined from the responses.
Table 2. The IC50 dose of E. billardieri extracts on PANC-1 and KDR/293 cells at 24 & 48 h.
Time | 24h | 48h | ||
Cell line | PANC-1 | KDR | PANC-1 | KDR |
n-hex | 836.2 | - | 217.3 | - |
DCM | 1128 | - | 306.8 | - |
Met | 1329 | - | 448.5 | - |
n-hex: n-hexane extracts; DCM: dichloromethane extracts; Met: methanol extracts
DCM and n-hex extracts of E. billardieri influenced on the Bax and Cyclin- D1 mRNA expression in PANC- 1 cancer cell lines
We used a QRT-PCR to evaluate the Bax and cyclin D1 expression in PANC- 1 and KDR/293 normal cell lines. According to the results of qRT-PCR (the obtained data are presented in Figure 3), the expression levels of Bax were significantly increased in PANC-1 cells after treatment with DCM and n-hex extracts with 100 and 200 µg/ mL concentration compared to untreated control cells and KDR/293 (p<0.05). Interestingly, the expression level of cyclin D1 mRNA decreased after treatment with DCM and n-hex extracts in the treated cancer cells compared to untreated control cells (p<0.05). Furthermore, there were not any significant differences in the expression levels of investigated genes subsequent to exposure KDR/293 normal cells (p>0.05). Unexpectedly, we did not see any difference in the expression levels of Bax and cyclin D1 genes subsequent to exposure cell lines with Met extract of E. billardieri (p>0.05). Upon to the results of QRT-PCR, it is obvious that none of the extracts at the concentration of 50µg/ mL had effects on genes expression in PANC-1 and KDR/293 cell lines (p>0.05).
DCM and n-hex extracts of E. billardieri induced apoptosis in PANC- 1 cancer cell lines
Figures 4 showed the representative FACS plots. The flow cytometry results represented that the untreated control KDR/293 and PANC-1 cells that primarily incubated by Annexin V and PI were approximately viable and no apoptosis and no necrosis occurred (97.8% & 85.2% respectively: Annexin V-/ PI-). Meanwhile, treatment with DCM and n-hex extracts in the highest determined dose (200 µg/ mL) for 48 h increased the percentage of PANC-1 cells in late (Annexin V+/PI+) apoptosis compared to the untreated control and normal KDR/293 cells. Our results revealed that Met extract of E. billardieri couldn’t be able to trigger apoptosis pathway in PANC-1 and KDR/293 cell lines (Annexin V-/PI-). However, DCM and n-hex extracts of E. billardieri might initiate apoptosis in KDR/293 cells at slow rate with highest determined dose (200 µg/ mL). In addition, after treatment with DCM and n-hex extracts of E. billardieri in three doses four groups including viable cells (Annexin V and PI negative), necrosis (Annexin V negative and PI positive), cells undergoing early apoptosis (Annexin V positive and PI negative), and cells in the late stage of apoptosis (Annexin V and PI positive) appeared. As a result, we can conclude that DCM and n-hex extracts of E. billardieri can induce a high level of apoptosis in treated cells (p<0.05).
Discussion
Pancreatic adenocarcinoma is the third leading cause of cancer-related death. Its highly lethal rate can be attributed to its poor prognosis and despite the advances in surgical intervention and chemotherapy; little effect has been made on the mortality rate of this disease. There is a serious need for complementary therapies with better efficacy. Previous in vitro studies about medicinal plants revealed that different species of Eryngium have demonstrated biological activities including cytotoxic, apoptotic, antimicrobial and anti-inflammatory.27 The focus of the present work was to investigate the molecular pathways including cell cycle arrest and apoptosis of E. billardieri and its antitumor cytotoxic effect.
In this study, it was found that DCM and n-hex extracts of E. billardieri could induce a high level of apoptosis in PANC-1 treated cells and kept the ratio of necrosis negligible. Moreover, these extracts increased the expression level of Bax mRNA in PANC-1 cell lines whereas the cyclin D1 expression was decreased in the treated cancer cells. As it was expected, the elevated expression of Bax mRNA was in line with apoptosis in PANC-1 treated cells.
Cell cycle progression is regulated at both the G to S and G to M transition states as a result of the activation and inactivation of specific protein kinases family and their regulatory subunits including cyclins and catalytic subunits which are termed cyclin-dependent kinases (Cdks). Till now, 11 members of the cyclins have been identified including cyclins A, B1±2, C, D1±3, E, F, G and H. The cyclin D1 plays a vital role in orchestrating cell progression through the G1 phase of the cell cycle and determines whether a cell will progress towards mitogenesis. Several observational studies have suggested that cyclin D1 plays a key role in promoting the growth of certain human malignancies.6,28 By considering various findings, nowadays it has been established that deregulation of cyclin D1 expression has contributed to the loss of cell cycle control and enhance tumorigenesis.29 A correlation has previously been pointed out between increased cyclin D1 and cancer formation.30,31 Based on the results of this study, the DCM and n-hex extracts of E. billardieri reduced cyclin D1expression in treated cancer cells with no effect on the normal cells.
We also confirmed that both E. billardieri extracts can stimulate Bax mRNA expression in PANC-1 cancer cells. Bax as a pro-apoptotic protein can trigger apoptosis by increasing the opening of the mitochondrial voltage-dependent anion channels, which induce the loss in its membrane potential.32 Our results suggest that the apoptotic mechanisms of n-hex extracts of E. billardieri in PANC-1 cells include the down regulation of cyclin D1 expression and the up regulation of Bax expression in a dose-dependent manner.
Our results replicate the findings of Esmaeili et al.14 who indicated the cytotoxic potential effects of E. billardieri on MCF-7, A549, HepG-2 and HT-29 cell lines. The main components of Eryngium species such as essential oils, sterols, saponin, and sanicula saponin are responsible for its cytotoxic activities. These compounds have shown potent and highly selective inhibition against PANC-1, HL-60, A549, PC-3, and MRC-5 tumor cell lines with almost no cytotoxicity against normal human cells.33,34
The hexane extract of various species of Eryngium exhibited anti-inflammatory and antioxidant activities in animal models.35 It has been mentioned that these effects may be due to a decrease in nitric oxide, inflammatory cytokines and TNF-α synthesis.36 In line with several investigations which attempted to find bioactive natural anticancer compounds, that induce apoptosis in cancer cells without cytotoxic effects against normal human cells, we indicated that the cytotoxic dose of DCM and n-hex extracts of E. billardieri did not cause a significant change in the survival rate of KDR/293 normal cells. The results of this study indicated that nonpolar extracts of E. billardieri were generally more effective than the methanolic ones. Similarly, Roumy et al37 showed the high cytotoxic/antiplasmodial effects of the DCM and n-hex extracts of some Amazonian plants. Therefore, the effective inhibition of PANC-1 cancer cells in vitro suggests that DCM and n-hex extracts of E. billardieri may be potentially promising anticancer agents for the effective treatment of pancreatic cancer cells. In this study, there are some limitations: 1) the examination of anticancer effects on PANC-1 cancer cells results to its effect to be unknown on other pancreatic cancer cell lines. 2) Lack of isolation and investigation of E. billardieri constituents.
Conclusion
In conclusion, the results of the current study are the first to indicate that DCM and n-hex extracts of E. billardieri significantly induce apoptosis by increasing Bax and decreasing cyclin D1 mRNA expression. However, more molecular studies for investigating the probable apoptotic pathways of the cytotoxic activity of E. billardieri should be conducted to achieve a definite conclusion.
Acknowledgments
The authors would like to thank the Nutrition Research Center of Tabriz University of Medical Sciences.
This study was funded by Tabriz University of Medical Sciences (grant number: IR.TBZMED.5.553473). The financial supporter of the study had no role in study design, data collection, data analysis, data interpretation, or writing the report. The corresponding author was well informed of all the data in the study and had final responsibility for the decision to submit for publication.
Ethical Issues
This project has met the principles of the Ethics Committee of Tabriz University of Medical Sciences (Ethical code: IR.TBZMED. REC. 1396. 618).
Conflict of Interest
The authors declare that they have no conflict of interest.
Abbreviations
Dimethylthiazole diphenyltetrazolium bromide assay: MTT assay; Quantitative Polymerase Chain Reaction: qPCR; Bcl2- associated X protein: BAX; Phosphate-buffered saline: PBS; Ethylenediaminetetraacetic acid: EDTA; Fetal bovine serum: FBS; Dimethyl sulfoxide: DMSO; Diethyl pyrocarbonate: DEPC; half maximal inhibitory concentration: IC50; Cyclin-dependent kinases: Cdks
References
- 1.Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049–57. doi: 10.1016/S0140-6736(04)15841-8. [DOI] [PubMed] [Google Scholar]
- 2.Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
- 3.Al-Wadei MH, Al-Wadei HA, Schuller HM. Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7. Mol Cancer Res. 2012;10(2):239–49. doi: 10.1158/1541-7786.MCR-11-0332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Réjiba S, Bigand C, Parmentier C, Hajri A. Gemcitabine-based chemogene therapy for pancreatic cancer using ad-dck:: Umk gdept and ts/rr sirna strategies. Neoplasia. 2009;11(7):637–50. doi: 10.1593/neo.81686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Abdullah JM, Ahmad F, Ahmad KA, Ghazali MM, Jaafar H, Ideris A. et al. Molecular genetic analysis of bax and cyclin d1 genes in patients with malignant glioma. Neurol Res. 2007;29(3):239–42. doi: 10.1179/016164107X158965. [DOI] [PubMed] [Google Scholar]
- 6.Kornmann M, Ishiwata T, Itakura J, Tangvoranuntakul P, Beger HG, Korc M. Increased cyclin d1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology. 1998;55(4):363–9. doi: 10.1159/000011879. [DOI] [PubMed] [Google Scholar]
- 7.Staibano S, Mignogna MD, Lo Muzio Lo, Di Alberti L, Di Natale E, Lucariello A. et al. Overexpression of cyclin-d1, bcl-2, and bax proteins, proliferating cell nuclear antigen (pcna), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol. 1998;29(11):1189–94. doi: 10.1016/s0046-8177(98)90244-1. [DOI] [PubMed] [Google Scholar]
- 8.Mansoori B, Mohammadi A, Hashemzadeh S, Shirjang S, Baradaran A, Asadi M. et al. Urtica dioica extract suppresses mir-21 and metastasis-related genes in breast cancer. Biomed Pharmacother. 2017;93:95–102. doi: 10.1016/j.biopha.2017.06.021. [DOI] [PubMed] [Google Scholar]
- 9.Xu ZW, Friess H, Büchler MW, Solioz M. Overexpression of bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents. Cancer Chemother Pharmacol. 2002;49(6):504–10. doi: 10.1007/s00280-002-0435-5. [DOI] [PubMed] [Google Scholar]
- 10.Mohammadi A, Mansoori B, Aghapour M, Baradaran B. Urtica dioica dichloromethane extract induce apoptosis from intrinsic pathway on human prostate cancer cells (pc3) Cell Mol Biol (Noisy-le-grand) 2016;62(3):78–83. [PubMed] [Google Scholar]
- 11.Yin SY, Wei WC, Jian FY, Yang NS. Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med. 2013;2013:302426. doi: 10.1155/2013/302426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mohammadi A, Mansoori B, Goldar S, Shanehbandi D, Khaze V, Mohammadnejad L. et al. Effects of urtica dioica dichloromethane extract on cell apoptosis and related gene expression in human breast cancer cell line (MDA-Mb-468) Cell Mol Biol (Noisy-le-grand) 2016;62(2):62–7. [PubMed] [Google Scholar]
- 13.Sefidkon F, Dabiri M, Alamshahi A. Chemical composition of the essential oil of eryngium billardieri f. Delaroche from iran. J Essent Oil Res. 2004;16(1):42–3. doi: 10.1080/10412905.2004.9698648. [DOI] [Google Scholar]
- 14.Esmaeili S, Irani M, Zehan HM, Keramatian B, Harandi ZT, Hamzeloo-Moghadam M. Cytotoxic activity of some ethnic medicinal plants from southwest of Iran. Res J Pharmacogn. 2016;3(1):43–7. [Google Scholar]
- 15.Yesilada E, Tanaka S, Tabata M, Sezik E. The antiinflammatory activity of the fractions from eryngium billardieri in mice. Phytother Res. 1989;3(1):38–40. doi: 10.1002/ptr.2650030111. [DOI] [Google Scholar]
- 16.Küpeli E, Kartal M, Aslan S, Yesilada E. Comparative evaluation of the anti-inflammatory and antinociceptive activity of turkish eryngium species. J Ethnopharmacol. 2006;107(1):32–7. doi: 10.1016/j.jep.2006.02.005. [DOI] [PubMed] [Google Scholar]
- 17.Gradiz R, Silva HC, Carvalho L, Botelho MF, Mota-Pinto A. Mia paca-2 and panc-1–pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648. doi: 10.1038/srep21648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tofighi Z, Asgharian P, Goodarzi S, Hadjiakhoondi A, Ostad SN, Yassa N. Potent cytotoxic flavonoids from iranian securigera securidaca. Med Chem Res. 2014;23(4):1718–24. doi: 10.1007/s00044-013-0773-3. [DOI] [Google Scholar]
- 19.Asnaashari S, Delazar A, Asgharian P, Lotfipour F, Bamdad Moghaddam S, Heshmati Afshar F. In-vitro bioactivity and phytochemical screening of extracts from rhizomes of eremostachys azerbaijanica rech. F. Growing in iran. Iran J Pharm Res. 2017;16(1):306–14. [PMC free article] [PubMed] [Google Scholar]
- 20.Asgharian P, Delazar A, Lotfipour F, Asnaashari S. Bioactive properties of eremostachys macrophylla montbr. & auch.Rhizomes growing in iran. Pharm Sci. 2017;23(3):238–43. doi: 10.15171/PS.2017.35. [DOI] [Google Scholar]
- 21.Yaripour S, Delnavazi MR, Asgharian P, Valiyari S, Tavakoli S, Nazemiyeh H. A survey on phytochemical composition and biological activity of zygophyllum fabago from iran. Adv Pharm Bull. 2017;7(1):109–14. doi: 10.15171/apb.2017.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Asgharian P, Afshar FH, Asnaashari S, Lotfipour F, Baradaran B, Zolali E. et al. Evaluation of various biological activities of the aerial parts of scrophularia frigida growing in iran. Iran J Pharm Res. 2017;16(1):277–89. [PMC free article] [PubMed] [Google Scholar]
- 23.Goodarzi S, Nateghpour M, Asgharian P, Hadjiakhoondi A, Yassa N, Tavakoli S. et al. Antimalarial and cytotoxic activities of roots and fruits fractions of astrodaucus persicus extract. Iran J Basic Med Sci. 2017;20(12):1318–23. doi: 10.22038/IJBMS.2017.9554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Afshar FH, Asgharian P, Khodaie L, Delazar A, Lotfipour F, Baradaran B. Anti-proliferative and antimicrobial activity of methanolic extract and SPE fractions of artemisia spicigera. Jundishapur J Nat Pharm Prod. 2016;in press:e36903. doi: 10.5812/jjnpp.36903. [DOI] [Google Scholar]
- 25.Delazar A, Asgharian P, Asnaashari S. Biological and phytochemical screening of eremostachys azerbaijanica rechF Aerial parts. Jundishapur J Nat Pharm Prod. 2017;12(3 (Supp)):e64312. doi: 10.5812/jjnpp.64312. [DOI] [Google Scholar]
- 26.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative pcr and the 2(- Delta Delta c(T)) method. Methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 27. Erdem SA, Nabavi SF, Orhan IE, Daglia M, Izadi M, Nabavi SM. Blessings in disguise: A review of phytochemical composition and antimicrobial activity of plants belonging to the genus eryngium. Daru 2015;23-53. doi: 10.1186/s40199-015-0136-3 [DOI] [PMC free article] [PubMed]
- 28.Graña X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (cdks), growth suppressor genes and cyclin-dependent kinase inhibitors (ckis) Oncogene. 1995;11(2):211–19. [PubMed] [Google Scholar]
- 29.Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta. 1993;1155(1):63–78. doi: 10.1016/0304-419x(93)90022-5. [DOI] [PubMed] [Google Scholar]
- 30.Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin d1 ablation. Nature. 2001;411(6841):1017–21. doi: 10.1038/35082500. [DOI] [PubMed] [Google Scholar]
- 31.Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N. et al. Overexpression of cyclin d1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res. 1997;57(9):1634–7. [PubMed] [Google Scholar]
- 32.Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the Cytosol to Mitochondria during Apoptosis. J Cell Biol. 1997;139(5):1281–91. doi: 10.1083/jcb.139.5.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wang P, Su Z, Yuan W, Deng G, Li S. Phytochemical constituents and pharmacological activities of eryngium l.(apiaceae) pharma crops. 2012;3:99–120. [Google Scholar]
- 34.Kartal M, Mitaine-Offer AC, Paululat T, Abu-Asaker M, Wagner H, Mirjolet JF. et al. Triterpene saponins from eryngium campestre. J Nat Prod. 2006;69(7):1105–8. doi: 10.1021/np060101w. [DOI] [PubMed] [Google Scholar]
- 35.Garcia MD, Saenz MT, Gomez MA, Fernandez MA. Topical antiinflammatory activity of phytosterols isolated from eryngium foetidum on chronic and acute inflammation models. Phytother Res. 1999;13(1):78–80. doi: 10.1002/(SICI)1099-1573(199902)13:1<78::AID-PTR384>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
- 36.Kartal M, Bzowska M, Koziel J, Szuba B, Dubiel O, Riviera Nunez D. et al. Anti-inflammatory effects of extracts from some traditional mediterranean diet plants. J Physiol Pharmacol Supplement. 2005;56(suppl 1):139–56. [PubMed] [Google Scholar]
- 37.Roumy V, Garcia-Pizango G, Gutierrez-Choquevilca AL, Ruiz L, Jullian V, Winterton P. et al. Amazonian plants from peru used by quechua and mestizo to treat malaria with evaluation of their activity. J Ethnopharmacol. 2007;112(3):482–9. doi: 10.1016/j.jep.2007.04.009. [DOI] [PubMed] [Google Scholar]